UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.805

Sortiert nach

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma : A multicenter phase II study

Blood, 1998-09, Vol.92 (6), p.1927-1932

1998

Volltextzugriff (PDF)

Does stretching increase ankle dorsiflexion range of motion? A systematic review

British journal of sports medicine, 2006-10, Vol.40 (10), p.870-875

2006

Volltextzugriff (PDF)

Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours

British journal of cancer, 2008-04, Vol.98 (8), p.1403-1414

2008

Volltextzugriff (PDF)

Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma

The Lancet (British edition), 2001-04, Vol.357 (9263), p.1172-1175

2001

Volltextzugriff (PDF)

Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors

British journal of cancer, 2013-06, Vol.108 (11), p.2399-2406

2013

Volltextzugriff (PDF)

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group

European journal of cancer (1990), 2001-05, Vol.37 (7), p.870-877

2001

Volltextzugriff (PDF)

Tositumomab and Iodine I 131 Tositumomab for Recurrent Indolent and Transformed B-Cell Non-Hodgkin’s Lymphoma

Journal of clinical oncology, 2004-04, Vol.22 (8), p.1469-1479

2004

Volltextzugriff (PDF)

The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage

British journal of cancer, 2009-08, Vol.101 (4), p.582-588

2009

Volltextzugriff (PDF)

Multicenter Phase II Study of Iodine-131 Tositumomab for Chemotherapy-Relapsed/Refractory Low-Grade and Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas

Journal of clinical oncology, 2000-03, Vol.18 (6), p.1316-1323

2000

Volltextzugriff (PDF)

International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphomas : Report of the jury

Journal of clinical oncology, 1999, Vol.17 (1), p.423-429

1999

Volltextzugriff (PDF)

Integrating personalised medicine into the routine cancer diagnostic pathway in Manchester, UK

Annals of oncology, 2018-09, Vol.29, p.vi8-vi8

2018

Volltextzugriff (PDF)

Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial

Annals of oncology, 2017-10, Vol.28 (10), p.2511-2516

2017

Volltextzugriff (PDF)

European Phase II Study of Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) for Patients With Newly Diagnosed Mantle-Cell Lymphoma and Previously Treated Mantle-Cell Lymphoma, Immunocytoma, and Small B-Cell Lymphocytic Lymphoma

Journal of clinical oncology, 2000-01, Vol.18 (2), p.317-324

2000

Volltextzugriff (PDF)

Testicular Function After Cytotoxic Chemotherapy: Evidence of Leydig Cell Insufficiency

Journal of clinical oncology, 1999-05, Vol.17 (5), p.1493-1498

1999

Volltextzugriff (PDF)

Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy

Clinical endocrinology (Oxford), 2001-09, Vol.55 (3), p.315-324

2001

Volltextzugriff (PDF)

Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

European journal of cancer (1990), 2000, Vol.36 (1), p.61-67

2000

Volltextzugriff (PDF)

Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL)

Annals of oncology, 2006-10, Vol.17 (10), p.1546-1552

2006

Volltextzugriff (PDF)

Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519)

Annals of oncology, 2010-03, Vol.21 (3), p.568-573

2010

Volltextzugriff (PDF)

Patterns of mortality after prolonged follow-up of a randomised controlled trial using granulocyte colony-stimulating factor to maintain chemotherapy dose intensity in non-Hodgkin's lymphoma

British journal of cancer, 2008-07, Vol.99 (2), p.253-258

2008

Volltextzugriff (PDF)

Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunction

British journal of cancer, 2000-02, Vol.82 (4), p.789-793

2000

Volltextzugriff (PDF)

Fertility after treatment for cancer

BMJ. British medical journal (International ed.), 1999-10, Vol.319 (7215), p.935

International edition, 1999

Volltextzugriff (PDF)

ChlVPP/EVA Hybrid Versus the Weekly VAPEC-B Regimen for Previously Untreated Hodgkin’s Disease

Journal of clinical oncology, 2002-07, Vol.20 (13), p.2988-2994

2002

Volltextzugriff (PDF)

Multicenter Phase II Study of Fludarabine Phosphate for Patients With Newly Diagnosed Lymphoplasmacytoid Lymphoma, Waldenström's Macroglobulinemia, and Mantle-Cell Lymphoma

Journal of clinical oncology, 1999-02, Vol.17 (2), p.546-553

1999

Volltextzugriff (PDF)

Follow up policy after treatment for Hodgkin's disease: too many clinic visits and routine tests? A review of hospital records

BMJ (Online), 1997-02, Vol.314 (7077), p.343

International edition, 1997

Volltextzugriff (PDF)

A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma

British journal of cancer, 2001-02, Vol.84 (4), p.465-469

2001

Volltextzugriff (PDF)

1 – 25 von 4.805

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.226)
Mit Volltextzugriff
(4.213)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

IngentaConnect
(2.154)
MEDLINE
(2.100)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(1.950)
EZB Electronic Journals Library
(1.897)
ScienceDirect
(1.294)
NUS Single-Journal Subscriptions
(1.230)
Wiley Online Library Journals
(1.047)
IngentaConnect Journals
(752)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(635)
Wiley Online Library Full Collection 2018
(435)
2022 ECC(Springer)
(236)
Oxford Journals
(229)
Nature Journals
(227)
APS: American Physical Society E-Journals (Physics)
(221)
American Physical Society
(210)
JSTOR All Journals
(204)
Oxford Journals 2020 Medicine
(169)
Taylor & Francis
(153)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(151)
Taylor & Francis Journals Complete
(147)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Alzheimer's & Dementia
(380)
Physical Review. C, Nuclear Physics
(129)
Physical Review Letters
(79)
Journal Of The American College Of Cardiology
(70)
Blood
(68)
Neurology
(67)
Journal Of Clinical Oncology
(61)
Journal Of Feline Medicine And Surgery
(54)
Circulation
(50)
Medical Journal Of Australia
(44)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(34)
... seit 30 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma : A multicenter phase II study

Does stretching increase ankle dorsiflexion range of motion? A systematic review

Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours

Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma

Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group

Tositumomab and Iodine I 131 Tositumomab for Recurrent Indolent and Transformed B-Cell Non-Hodgkin’s Lymphoma

The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage

Multicenter Phase II Study of Iodine-131 Tositumomab for Chemotherapy-Relapsed/Refractory Low-Grade and Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas

International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphomas : Report of the jury

Integrating personalised medicine into the routine cancer diagnostic pathway in Manchester, UK

Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial

European Phase II Study of Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) for Patients With Newly Diagnosed Mantle-Cell Lymphoma and Previously Treated Mantle-Cell Lymphoma, Immunocytoma, and Small B-Cell Lymphocytic Lymphoma

Testicular Function After Cytotoxic Chemotherapy: Evidence of Leydig Cell Insufficiency

Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy

Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group

Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL)

Initial dose intensity has limited impact on the outcome of ABVD chemotherapy for advanced Hodgkin lymphoma (HL): data from UKLG LY09 (ISRCTN97144519)

Patterns of mortality after prolonged follow-up of a randomised controlled trial using granulocyte colony-stimulating factor to maintain chemotherapy dose intensity in non-Hodgkin's lymphoma

Fatigue, sexual function and mood following treatment for haematological malignancy: the impact of mild Leydig cell dysfunction

Fertility after treatment for cancer

ChlVPP/EVA Hybrid Versus the Weekly VAPEC-B Regimen for Previously Untreated Hodgkin’s Disease

Multicenter Phase II Study of Fludarabine Phosphate for Patients With Newly Diagnosed Lymphoplasmacytoid Lymphoma, Waldenström's Macroglobulinemia, and Mantle-Cell Lymphoma

Follow up policy after treatment for Hodgkin's disease: too many clinic visits and routine tests? A review of hospital records

A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma

Suchergebnisse filtern